Scarica l'app Stockscreener
1.5676
4.73%
0.0876
Precedente Chiudi:
$1.48
Aprire:
$1.52
Volume 24 ore:
101.75K
Relative Volume:
0.39
Capitalizzazione di mercato:
$7.94M
Reddito:
-
Utile/perdita netta:
$-21.13M
Rapporto P/E:
-0.3273
EPS:
-4.79
Flusso di cassa netto:
$-16.95M
1 W Prestazione:
+72.22%
1M Prestazione:
+50.49%
6M Prestazione:
+158.33%
1 anno Prestazione:
+900.00%
Intervallo 1D:
$1.33
$1.5799
Intervallo di 1 settimana:
$0.84
$1.85
Portata 52W:
$0.09
$4.49
Matinas Biopharma Holdings Inc Stock (MTNB) Company Profile
Nome
Matinas Biopharma Holdings Inc
Settore
Industria
Telefono
908-443-1860
Indirizzo
1545 Route 206 South, Suite 302, Bedminster, NJ
Confronta MTNB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MTNB
Matinas Biopharma Holdings Inc
|
1.56 | 8.14M | 0 | -21.13M | -16.95M | -4.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.12 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.50 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
436.02 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
645.90 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
303.40 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Matinas Biopharma Holdings Inc Stock (MTNB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-05-11 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-08-26 | Ripresa | Piper Sandler | Overweight |
| 2020-01-27 | Iniziato | Piper Sandler | Overweight |
| 2020-01-24 | Iniziato | SunTrust | Buy |
| 2020-01-23 | Iniziato | SunTrust | Buy |
| 2020-01-09 | Iniziato | Aegis Capital | Buy |
| 2019-06-26 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Matinas Biopharma Holdings Inc Borsa (MTNB) Ultime notizie
Matinas BioPharma Holdings Inc. Shows Early Signs of Technical Strength [2025 Risk Factors]Accurate Entry/Exit Alerts - 선데이타임즈
Can technical indicators confirm Matinas BioPharma Holdings Inc.’s reversalWeekly Volume Report & Entry and Exit Point Strategies - Newser
Matinas BioPharma Holdings Inc. recovery potential after sell offJuly 2025 Review & Comprehensive Market Scan Reports - Newser
Has Matinas BioPharma Holdings Inc. found a price floorPortfolio Risk Summary & Short-Term Swing Trade Alerts - Newser
Matinas Biopharma Holdings Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - investchronicle.com
Can Matinas BioPharma Holdings Inc. reach all time highs this yearMulti-Fold Return Candidates - newsyoung.net
Price Channel Expanding on Matinas BioPharma Holdings Inc.’s ChartROI Boosting Trade Opportunity Calendar Published - beatles.ru
Will Matinas BioPharma Holdings Inc. bounce back from current supportEarnings Report Summary with Market Impact - Newser
Published on: 2025-08-11 01:10:21 - Newser
Detecting price anomalies in Bank of the James Financial Group Inc. with AIFree Weekly Top Gainers Forecast Watchlist - Newser
Can volume confirm reversal in Matinas BioPharma Holdings Inc.Equity Forecast with Predictive AI Screener - Newser
Is this a good reentry point in Matinas BioPharma Holdings Inc.Market Opportunity Tracker for Swing Traders - Newser
When is the best time to buy Toppoint Holdings Inc. stock3-Year Equity Summary With Setup Insights - Newser
Key resistance and support levels for Matinas BioPharma Holdings Inc.Asset Allocation Summary With Future Outlook - Newser
Matinas BioPharma Doubles Authorized Common Shares To 500M Following Shareholder Approval - 富途牛牛
What institutional flow reveals about Matinas BioPharma Holdings Inc.Low Drawdown Picks with Weekly Updates - Newser
How to read the order book for Matinas BioPharma Holdings Inc.Market Sentiment Tracker with Smart Alerts - Newser
How to build a custom watchlist for GT Biopharma Inc.Deep Learning Stock Forecast for Investors - Newser
Why Matinas BioPharma Holdings Inc. stock attracts strong analyst attentionTechnical Chart Summary for Momentum Stocks - Newser
How many analysts rate Matinas BioPharma Holdings Inc. as a “Buy”Discover high-growth stocks for your portfolio - Jammu Links News
What makes Matinas BioPharma Holdings Inc. stock price move sharplyFree Real-Time Market Sentiment Tracking Tool - Newser
Matinas BioPharma Holdings Inc. Stock Support and Resistance Levels You Should KnowFree Weekly Hot Picks With Buy Confidence - Newser
Should I hold or sell Matinas BioPharma Holdings Inc. stock in 2025Achieve exceptional returns with expert guidance - Jammu Links News
How strong is Matinas BioPharma Holdings Inc. company’s balance sheetMaximize returns with effective portfolio management - Jammu Links News
What institutional investors are buying Matinas BioPharma Holdings Inc. stockFree Expert Stock Watchlist - Jammu Links News
When is Matinas BioPharma Holdings Inc. stock expected to show significant growthUnlock exclusive trading strategies - Jammu Links News
How does Matinas BioPharma Holdings Inc. compare to its industry peersStrongest growth potential - Jammu Links News
How does Matinas BioPharma Holdings Inc. generate profit in a changing economySuperior investment outcomes - Jammu Links News
Is Matinas BioPharma Holdings Inc. stock overvalued or undervaluedFree Investment Timing Strategies - Jammu Links News
What is the dividend policy of Matinas BioPharma Holdings Inc. stockHigh-velocity capital appreciation - Jammu Links News
What are analysts’ price targets for Matinas BioPharma Holdings Inc. in the next 12 monthsIdentify undervalued stocks poised to rally - jammulinksnews.com
What are Matinas BioPharma Holdings Inc. company’s key revenue driversAchieve remarkable returns with smart investing - jammulinksnews.com
Is Matinas BioPharma Holdings Inc. a good long term investmentMaximize your returns with expert insights - Jammu Links News
What is the risk reward ratio of investing in Matinas BioPharma Holdings Inc. stockSwing Trade Review With Proven Results - Jammu Links News
Can Matinas BioPharma Holdings Inc. recover in the next quarterFree Technical Entry Strategy for Beginners - Newser
What the charts say about Clear Secure Inc. todayPredictive AI Signals for Short-Term Trading - Newser
Matinas Biopharma Holdings Inc Azioni (MTNB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.85%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):